ArticleAlzheimer's & dementia (New York, N. Y.)

Recruitment and eligibility in a Phase 1 early Alzheimer's disease trial of Sabirnetug.

Robyn Moxon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.